NEUROONE MEDICAL TECHNOLOGIE (NMTC)

US64130M2098 - Common Stock

1.13  +0.01 (+0.89%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-12-31)
2023
(2023-9-30)
2022
(2022-9-30)
2021
(2021-9-30)
2020
(2020-9-30)
Revenue
2.86M3.45M2.12M240.00K1.93M
Cost Of Goods
2.08M1.50M240.00K280.00KN/A
Gross Profit
770.70K1.95M1.88M-30.00KN/A
Operating Expenses
14.34M13.91M11.91M10.18M6.83M
Research and Development
6.86M6.94M4.93M3.93M2.08M
Selling, General, and Administrative Expenses
7.43M6.93M6.98M6.26M4.75M
Operating Income
-13.57M-11.96M-10.03M-10.22M-4.90M
Interest Income/Expense
N/AN/A0.000.00-6.72M
Other Income/Expense
85.20K95.76K30.00K270.00KN/A
Non Recurring Items
N/AN/AN/AN/A-2.02M
Income Before Taxes
-13.47M-11.86M-10.00M-9.95M-13.64M
Income Tax
0.000.00N/AN/AN/A
Net Income
-13.47M-11.86M-10.00M-9.95M-13.64M
EBITDA
-13.35M-11.76M-9.91M-10.14M-4.85M
 
Per Share Data
EPS Diluted Total Ops
-0.69-0.65-0.63-0.93-2.52
Non GAAP EPS
-0.68-0.65-0.63N/AN/A
 
Statistics
Gross Profit Margin
26.95%56.62%88.68%-12.50%N/A
Profit Margin
-470.95%-343.92%-471.70%-4145.83%-706.74%
Operating Profit Margin
-474.28%-346.69%-473.11%-4258.33%-253.89%

All data in USD

Charts